ECM Weekly (10th October 2021) - Japan Post, MicroPort Medbot, MicroTech, FWD, Medbanks, 4Paradigm
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
521 Views
MicroTech Medical IPO: Valuation Insights
Our valuation analysis suggests that the IPO price range is full and we would remain on the sidelines awaiting a better entry opportunity.
463 Views
MicroTech Medical IPO: Forecasts and Valuation
Our DCF and relative valuation suggests that MicroTech's shares are expensive at the IPO price range. Company is also facing intense competition...
500 Views
MicroTech Medical IPO Initiation: Fighting Diabetes
Microtech has launched an HKEx IPO to raise net proceeds of $225 m. Microtech has three categories of commercialised products and is worth a look at.
350 Views
MicroTech IPO: Strong Product Portfolio; Small Demand Compared to Other Diabetes Treatment Options
The company's core product Equil is priced at a discount to Medtronic's tube insulin pump which should eventually capture market share from...
360 Views